Notable companies
The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), ABBVIE (NYSE:ABBV), AstraZeneca PLC (NASDAQ:AZN), Pfizer (NYSE:PFE), Amgen (NASDAQ:AMGN), Bristol-Myers Squibb Co (NYSE:BMY), Regeneron Pharmaceuticals (NASDAQ:REGN), Biogen (NASDAQ:BIIB).
Industry description
The investment seeks to provide long-term growth of capital.
The fund is an actively-managed exchange-traded fund (“ETF”) that pursues its investment objective by investing, under normal circumstances, at least 80% of its net assets plus any borrowings for investment purposes in common stocks, convertible securities, warrants and other equity securities having the characteristics of common stocks of U.S. and foreign companies engaged in medical research, pharmaceutical and medical technology industries and related technology industries. The fund is non-diversified.
Market Cap
The average market capitalization across the Horizon Kinetics Medical ETF ETF is 89.19B. The market cap for tickers in the group ranges from 2.11M to 739.66B. LLY holds the highest valuation in this group at 739.66B. The lowest valued company is SLRX at 2.11M.
High and low price notable news
The average weekly price growth across all stocks in the Horizon Kinetics Medical ETF ETF was 0%. For the same ETF, the average monthly price growth was 4%, and the average quarterly price growth was 1%. IONS experienced the highest price growth at 7%, while GALT experienced the biggest fall at -29%.
Volume
The average weekly volume growth across all stocks in the Horizon Kinetics Medical ETF ETF was -26%. For the same stocks of the ETF, the average monthly volume growth was -1% and the average quarterly volume growth was 23%
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Valuation Rating: 47
P/E Growth Rating: 76
Price Growth Rating: 55
SMR Rating: 71
Profit Risk Rating: 80
Seasonality Score: 29 (-100 ... +100)